Canada · Delayed Price · Currency is CAD MedX Health Statistics
Total Valuation
MedX Health has a market cap or net worth of CAD 19.68 million. The enterprise value is 28.11 million.
| Market Cap | 19.68M |
| Enterprise Value | 28.11M |
Important Dates
The next estimated earnings date is Thursday, April 30, 2026.
| Earnings Date | Apr 30, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MedX Health has 327.93 million shares outstanding. The number of shares has increased by 10.21% in one year.
| Current Share Class | 327.93M |
| Shares Outstanding | 327.93M |
| Shares Change (YoY) | +10.21% |
| Shares Change (QoQ) | +3.78% |
| Owned by Insiders (%) | 6.41% |
| Owned by Institutions (%) | n/a |
| Float | 216.15M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 37.63 |
| PB Ratio | -1.96 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -5.29 |
| EV / Sales | 53.75 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.10
| Current Ratio | 0.10 |
| Quick Ratio | 0.06 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -1.71 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -196.91% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 39.67% |
| Weighted Average Cost of Capital (WACC) | 16.41% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | 0.49 |
| Inventory Turnover | 0.87 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -25.00% in the last 52 weeks. The beta is 2.06, so MedX Health's price volatility has been higher than the market average.
| Beta (5Y) | 2.06 |
| 52-Week Price Change | -25.00% |
| 50-Day Moving Average | 0.06 |
| 200-Day Moving Average | 0.07 |
| Relative Strength Index (RSI) | 40.77 |
| Average Volume (20 Days) | 81,750 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, MedX Health had revenue of CAD 522,904 and -5.32 million in losses. Loss per share was -0.02.
| Revenue | 522,904 |
| Gross Profit | 175,694 |
| Operating Income | -3.36M |
| Pretax Income | -5.32M |
| Net Income | -5.32M |
| EBITDA | -3.39M |
| EBIT | -3.36M |
| Loss Per Share | -0.02 |
Balance Sheet
The company has 25,513 in cash and 8.46 million in debt, with a net cash position of -8.43 million or -0.03 per share.
| Cash & Cash Equivalents | 25,513 |
| Total Debt | 8.46M |
| Net Cash | -8.43M |
| Net Cash Per Share | -0.03 |
| Equity (Book Value) | -10.02M |
| Book Value Per Share | -0.03 |
| Working Capital | -8.77M |
Cash Flow
| Operating Cash Flow | -3.17M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | 33.60% |
| Operating Margin | -641.95% |
| Pretax Margin | -1,016.88% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MedX Health does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.21% |
| Shareholder Yield | -10.21% |
| Earnings Yield | -27.02% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MedX Health has an Altman Z-Score of -81.21 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -81.21 |
| Piotroski F-Score | 4 |